Business Context and Reporting Period
The filing is a Form 8-K for Flora Growth Corp., dated April 26, 2024, and signed April 29, 2024. The provided request metadata identifies Zerostack Corp., but the filing names Flora Growth Corp. as the registrant. Flora Growth’s common shares trade under the symbol FLGC on the Nasdaq Capital Market.
Material Agreement and Key Terms
On April 26, 2024, Flora Growth entered into an At-The-Market Issuances Sales Agreement with Aegis Capital Corp. as sales agent. The agreement permits Flora Growth, at its option, to sell common shares from time to time under its existing Form S-3 registration statement, File No. 333-274204.
- Sales may be conducted through methods qualifying as an “at-the-market offering” under Rule 415(a)(4).
- The company determines, in consultation with the agent, the maximum amount of shares to be sold and may specify minimum acceptable prices.
- Flora Growth is not obligated to sell any shares.
- The agent may receive compensation of up to 3.0% of gross proceeds from each sale.
- The company agreed to provide customary indemnification and contribution to the agent for certain liabilities, including Securities Act liabilities.
- The offering may be suspended and terminates under the circumstances specified in the agreement.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margin, debt, cash balance, liquidity, or other operating performance metrics. No actual share sales or proceeds under the agreement were reported in the provided filing text.
Changes, Outlook, and Risks
The material change is the establishment of a potential equity financing facility. If shares are sold, the transaction could provide additional capital but may dilute existing shareholders. The filing does not provide management guidance, an operating outlook, or specific use-of-proceeds information in the provided text.
Potential risks include equity dilution, market-price volatility, execution risk, the agent’s ability to sell shares, and the company’s obligation to indemnify the agent for specified liabilities. The agreement description is qualified by the complete agreement filed as Exhibit 1.1.
Investor Verification Checklist
- Verify the registrant identity because the request metadata names Zerostack Corp., while the filing names Flora Growth Corp.
- Review Exhibit 1.1 for termination provisions, selling restrictions, and other detailed agreement terms.
- Determine the maximum share capacity available under the Form S-3 registration statement and whether any sales have occurred subsequently.
- Assess potential dilution based on shares outstanding before and after any at-the-market sales.
- Review Flora Growth’s latest periodic filings for cash needs, liquidity, debt, and intended use of any offering proceeds.